| IDEOGEN AG - Glassia 20 mg/ml, Infusionslösung |
| 68833 | | 01 | | Glassia 20 mg/ml | | Infusionslösung | | B02AB02 | | Alfa1 Antitrypsin | | 20.04.2023 | | |
|
| Composition |
| alpha-1-proteinasi inhibitor humanum 1000 mg, natrii dihydrogenophosphas dihydricus, natrii chloridum, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 50 ml, natrium 149.5-195.5 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Alpha-1-Proteinasi Inhibitor Humanum | 1000mg / 50ml |
| | BAG: Active Agent | Dose |
|---|
| Alpha-1-Proteinasi Inhibitor Humanum | 1000 mg |
| | | | Inactive agents |
|---|
| Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Natrii Hydroxidum ad Ph |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 330.72 | 380.35 | B | SL | No |
|
